Standard Biotools Inc. Revenue 2009–2025
Standard Biotools Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Standard Biotools Inc. revenue for the quarter ending March 31, 2026 was 21.1 M, a 4.57% increase year-over-year.
- Standard Biotools Inc. revenue for the twelve months ending March 31, 2026 was 82.7 M, a 28.40% decrease year-over-year.
- Standard Biotools Inc. annual revenue for 2025 was 85.3 M, a 6.24% decrease from 2024.
- Standard Biotools Inc. annual revenue for 2024 was 91.0 M, a 14.42% decrease from 2023.
- Standard Biotools Inc. annual revenue for 2023 was 106.3 M, a 8.57% increase from 2022.
- Standard Biotools Inc. annual revenue for 2022 was 97.9 M.
Standard Biotools Inc. (LAB) — Frequently Asked Questions
Standard Biotools Inc. (LAB) is a publicly traded US company. It has a market capitalization of $346M. In fiscal 2025 it reported revenue of $85M and net income of -$75M. Explore LAB's stock price, financial statements, earnings history, margins and key ratios below.
What is Standard Biotools Inc.'s market cap?
Standard Biotools Inc. (LAB) has a market capitalization of $346M.
What is the LAB stock price?
LAB trades at $0.91 (+3.06% on the day).
How much revenue does Standard Biotools Inc. make?
Standard Biotools Inc. reported revenue of $85M in fiscal 2025.
Is LAB profitable?
In fiscal 2025, Standard Biotools Inc. reported net income of -$75M.